CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
Flinders University
Adelaida, AustraliaPublicacions en col·laboració amb investigadors/es de Flinders University (20)
2020
-
Delay from treatment start to full effect of immunotherapies for multiple sclerosis
Brain, Vol. 143, Núm. 9, pp. 2742-2756
2019
-
Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study
Multiple Sclerosis and Related Disorders, Vol. 28, pp. 235-243
2018
-
Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis
Multiple Sclerosis Journal, Vol. 24, Núm. 5, pp. 642-652
2017
-
Contribution of different relapse phenotypes to disability in multiple sclerosis
Multiple Sclerosis, Vol. 23, Núm. 2, pp. 266-276
-
Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 88, Núm. 3, pp. 196-203
2016
-
Defining secondary progressive multiple sclerosis
Brain, Vol. 139, Núm. 9, pp. 2395-2405
-
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 87, Núm. 12, pp. 1343-1349
-
The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis
Multiple Sclerosis, Vol. 22, Núm. 4, pp. 520-532
2015
-
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis
Multiple Sclerosis, Vol. 21, Núm. 9, pp. 1159-1171
-
Defining reliable disability outcomes in multiple sclerosis
Brain, Vol. 138, Núm. 11, pp. 3287-3298
-
Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry
Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 1
-
Predictors of disability worsening in clinically isolated syndrome
Annals of Clinical and Translational Neurology, Vol. 2, Núm. 5, pp. 479-491
-
Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis
Annals of Neurology, Vol. 77, Núm. 3, pp. 425-435
2014
-
Seasonal variation of relapse rate in multiple sclerosis is latitude dependent
Annals of Neurology, Vol. 76, Núm. 6, pp. 880-890
2013
-
Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis
PLoS ONE, Vol. 8, Núm. 5
-
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
Brain, Vol. 136, Núm. 12, pp. 3609-3617
2012
-
Country, sex, edss change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome
PLoS ONE, Vol. 7, Núm. 6
-
Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis
PLoS ONE, Vol. 7, Núm. 10
-
Increasing age at disability milestones among MS patients in the MSBase Registry
Journal of the Neurological Sciences, Vol. 318, Núm. 1-2, pp. 94-99
-
The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude
Multiple Sclerosis Journal, Vol. 18, Núm. 7, pp. 974-982